MedPath

GE Healthcare AS

🇳🇴Norway
Ownership
Subsidiary
Established
1874-01-01
Employees
-
Market Cap
-
Website
http://www.gehealthcare.no

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

66

NMPA:63
EMA:3

Drug Approvals

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181149
Approval Date
Jan 24, 2024
NMPA

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181151
Approval Date
Jan 24, 2024
NMPA

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181152
Approval Date
Jan 24, 2024
NMPA

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181154
Approval Date
Jan 24, 2024
NMPA

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181150
Approval Date
Jan 24, 2024
NMPA

Gadodiamide Injection

Product Name
欧乃影
Approval Number
国药准字HJ20181153
Approval Date
Jan 24, 2024
NMPA

Iodixanol Injection

Product Name
威视派克
Approval Number
国药准字HJ20181169
Approval Date
Jan 15, 2024
NMPA

Iodixanol Injection

Product Name
威视派克
Approval Number
国药准字HJ20181164
Approval Date
Jan 15, 2024
NMPA

Iodixanol Injection

Product Name
威视派克
Approval Number
国药准字HJ20191016
Approval Date
Jan 15, 2024
NMPA

Iodixanol Injection

Product Name
威视派克
Approval Number
国药准字HJ20201004
Approval Date
Jan 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath